Clinical trial
Breast Cancer Study of Preoperative Pembrolizumab + Radiation
NCT03366844
Study timeline
Study start (actual)2017-12-22Date precision: day
Registry last updated2026-04-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
PembrolizumabDRUG · verified · RxNorm: pembrolizumab
RT BoostRADIATION
Sponsors & collaborators
Stephen Shiaolead sponsor
United States Department of Defensecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03366844 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.